Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Limeum indicum ethanol extract is a **plant-derived natural product extract** prepared from *Limeum indicum* and investigated only in **preclinical research**. Available evidence describes a multifunctional extract with **enzyme inhibitory**, **antioxidant**, and **hypoglycemic** activity, including reported inhibition of **butyrylcholinesterase**, **alpha-glucosidase**, **beta-glucosidase**, and related neuro-metabolic targets evaluated in screening assays. In an in vivo study, the ethanol extract showed hypoglycemic effects after 21 days of treatment at 250 and 500 mg/kg, supporting exploratory development interest in **Type 2 diabetes mellitus** and potentially **Alzheimer's disease** dual-therapy concepts. No pharmaceutical brand name, commercial developer, regulatory approval, or established clinical development program has been identified for this specific extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on limeum indicum ethanol extract.